What is Topicals?
Founded in 2010, Topicals is a skincare company dedicated to providing solutions for chronic skin issues such as eczema, hyperpigmentation, and psoriasis. The brand has established a strong retail presence, notably through its distribution at Sephora, positioning itself as a key player in the consumer health and beauty market. The company's focus on scientifically-backed formulations for common dermatological concerns resonates with a broad consumer base seeking effective treatments.
How much funding has Topicals raised?
Topicals has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2022): $10M with participation from Cavu Consumers Partners
Key Investors in Topicals
Cavu Consumers Partners
Cavu Consumers Partners is an investor in the company's funding round. Further details on their investment focus are not publicly available.
What's next for Topicals?
The recent major strategic investment signals a pivotal growth phase for Topicals. This capital infusion is expected to fuel further product development, expand market reach, and potentially enhance research into novel therapeutic approaches for skin conditions. The company's trajectory suggests a move towards scaling its operations and solidifying its position as a leader in the specialized skincare sector, leveraging its established brand recognition and product efficacy.
See full Topicals company page
